Acelrx Pharmaceuticals reported $15.65M in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acelrx Pharmaceuticals ACRX:US USD 15.65M 2.04M
Baxter International BAX:US USD 4.74B 1.04B
Becton, Dickinson and BDX:US USD 7.63B 186M
Cara Therapeutics CARA:US USD 23.46M 4.73M
Heron Therapeutics HRTX:US USD 93.88M 15.62M
Intra Cellular Therapies ITCI:US USD 83.24M 5.83M
Pain Therapeutics PTIE:US USD 7.06M 1.24M
Smiths SMIN:LN GBP 1.41B 7M
Teva Pharmaceutical TEVA:IT USD 11.47B 65M
Xeris Pharmaceuticals Inc XERS:US USD 73.62M 5.06M